CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy.

Cells · 2020 · PMC7226963 · PMID 32294968

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the differences in tumors treated with BLR100 or BLR200 compared to controls did not reach statistical significance, the inhibition induced by the two peptides was reproducible and obtained with multiple preparations of the peptides.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.